CA2223505A1 - Anti-fungal and anti-bacterial histatin-based peptides - Google Patents

Anti-fungal and anti-bacterial histatin-based peptides

Info

Publication number
CA2223505A1
CA2223505A1 CA002223505A CA2223505A CA2223505A1 CA 2223505 A1 CA2223505 A1 CA 2223505A1 CA 002223505 A CA002223505 A CA 002223505A CA 2223505 A CA2223505 A CA 2223505A CA 2223505 A1 CA2223505 A1 CA 2223505A1
Authority
CA
Canada
Prior art keywords
fungal
based peptides
histatin
bacterial
naturally occurring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002223505A
Other languages
French (fr)
Other versions
CA2223505C (en
Inventor
Frank G. Oppenheim
Tao Xu
F. Donald Roberts
Peter Spacciapoli
Phillip M. Friden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Demegen Inc
Original Assignee
Frank G. Oppenheim
Tao Xu
F. Donald Roberts
Peter Spacciapoli
Phillip M. Friden
Periodontix, Inc.
Trustees Of Boston University
Demegen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frank G. Oppenheim, Tao Xu, F. Donald Roberts, Peter Spacciapoli, Phillip M. Friden, Periodontix, Inc., Trustees Of Boston University, Demegen, Inc. filed Critical Frank G. Oppenheim
Publication of CA2223505A1 publication Critical patent/CA2223505A1/en
Application granted granted Critical
Publication of CA2223505C publication Critical patent/CA2223505C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Histatin-based peptides representing defined portions of the amino acid sequences of naturally occurring human histatins and methods for treatment of fungal or bacterial infection are described. These histatin-based peptides represent the active anti-fungal and anti-bacterial region of naturally occurring human histatins.
CA002223505A 1995-06-07 1996-06-07 Anti-fungal and anti-bacterial histatin-based peptides Expired - Fee Related CA2223505C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/481,888 US5631228A (en) 1991-11-01 1995-06-07 Anti-fungal and anti-bacterial histatin-based peptides
US08/481,888 1995-06-07
PCT/US1996/009374 WO1996040768A2 (en) 1995-06-07 1996-06-07 Anti-fungal and anti-bacterial histatin-based peptides

Publications (2)

Publication Number Publication Date
CA2223505A1 true CA2223505A1 (en) 1996-12-19
CA2223505C CA2223505C (en) 2003-10-14

Family

ID=23913789

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002223505A Expired - Fee Related CA2223505C (en) 1995-06-07 1996-06-07 Anti-fungal and anti-bacterial histatin-based peptides

Country Status (11)

Country Link
US (1) US5631228A (en)
EP (1) EP0832119B1 (en)
JP (1) JPH11508238A (en)
AT (1) ATE196475T1 (en)
AU (1) AU709204B2 (en)
CA (1) CA2223505C (en)
DE (1) DE69610424T2 (en)
DK (1) DK0832119T3 (en)
ES (1) ES2151172T3 (en)
IL (1) IL122386A0 (en)
WO (1) WO1996040768A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
DE69613485T2 (en) * 1995-11-03 2001-10-31 Unilever Nv NATURAL COMPOSITION FOR MUSHROOMS
US6531573B1 (en) 1997-12-18 2003-03-11 Trustees Of Boston University Antifungal and antibacterial peptides
NL1008745C2 (en) * 1998-03-30 1999-10-01 Stichting Tech Wetenschapp New peptide conjugates useful for treating yeast, fungal and bacterial infections and tumors
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6528488B2 (en) * 1999-01-08 2003-03-04 Demegen, Inc. Method for treating cystic fibrosis
US6800291B1 (en) * 1999-03-24 2004-10-05 Zengen, Inc. Uro-genital condition treatment system
US6833435B2 (en) * 1999-08-23 2004-12-21 Matthew Glenn Compositions isolated from bovine tissues and methods for their use
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
CA2285673C (en) 1999-10-21 2008-07-29 Gilles Andre Lajoie Cyclic analogs of histatins
CA2412011A1 (en) 2000-06-16 2001-12-27 Hercules Incorporated Chemically-modified antimicrobial peptides, compositions and methods of production and use
US6576226B1 (en) * 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US7090497B1 (en) 2001-02-21 2006-08-15 Harris David M Method of periodontal laser treatment
US20040127892A1 (en) * 2002-01-31 2004-07-01 Harris David M. Periodontal laser and methods
US7033769B2 (en) 2002-05-23 2006-04-25 The United States Of America As Represented By The Secretary Of The Army Method for discovering one or more peptides adapted for specific binding to a microorganism of interest
US7087228B2 (en) * 2002-07-03 2006-08-08 University Of Southern California Preventing tooth decay and infective endocarditis using natural oligopeptides
EP1616035A4 (en) 2003-04-01 2007-02-21 Univ Southern California Caries risk test for predicting and assessing the risk of disease
US9127045B2 (en) * 2005-11-17 2015-09-08 University Of Southern California Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides
WO2009005798A2 (en) * 2007-07-03 2009-01-08 Pacgen Biopharmaceuticals Corporation Antifungal formulation and method of preparation
US20130288964A1 (en) 2008-01-07 2013-10-31 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Pa Use of peptides for promoting wound healing
MX2010007442A (en) * 2008-01-07 2010-12-21 Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg Use of peptides for promoting wound healing.
US20100047734A1 (en) * 2008-08-20 2010-02-25 PathoLase, Inc. Periodontal laser treatment and laser applicator
US8992223B2 (en) * 2010-02-19 2015-03-31 The University Of South Dakota Rechargeable long-term antifungal denture materials
US20130310327A1 (en) 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US20170022256A1 (en) * 2015-07-23 2017-01-26 General Biologicals Corporation Anti-fungal and anti-bacterial peptide and therapeutic method using same
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN116848129A (en) * 2021-02-16 2023-10-03 香港大学 Antibacterial and mineralizing compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US5221732A (en) * 1988-12-06 1993-06-22 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial magainin modified peptides
JP2818056B2 (en) * 1990-09-07 1998-10-30 森永乳業株式会社 Antimicrobial peptides and antimicrobial agents
US5225399A (en) * 1991-04-15 1993-07-06 The Children's Hospital Of Philadelphia Antimicrobial amphiphilic peptides
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides
US5324716A (en) * 1991-06-14 1994-06-28 Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US5486503A (en) * 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
JPH06234653A (en) * 1993-02-10 1994-08-23 Sunstar Inc Periodontium regeneration accelerating agent and material therefor
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
JPH06287146A (en) * 1993-03-31 1994-10-11 Sunstar Inc External agent for skin

Also Published As

Publication number Publication date
DE69610424D1 (en) 2000-10-26
CA2223505C (en) 2003-10-14
IL122386A0 (en) 1998-06-15
ATE196475T1 (en) 2000-10-15
WO1996040768A2 (en) 1996-12-19
DE69610424T2 (en) 2001-01-25
WO1996040768A3 (en) 1997-03-06
JPH11508238A (en) 1999-07-21
US5631228A (en) 1997-05-20
AU6158596A (en) 1996-12-30
ES2151172T3 (en) 2000-12-16
EP0832119B1 (en) 2000-09-20
EP0832119A2 (en) 1998-04-01
DK0832119T3 (en) 2000-11-20
AU709204B2 (en) 1999-08-26

Similar Documents

Publication Publication Date Title
CA2223505A1 (en) Anti-fungal and anti-bacterial histatin-based peptides
WO1996040770A3 (en) Anti-fungal d-amino acid histatin-based peptides
CA2381770A1 (en) Human ctla-4 antibodies and their uses
CA2180950A1 (en) Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
AU5370096A (en) Method of treating or preventing non-viral microbial infection
WO2003015809A3 (en) Antimicrobial cationic peptides and formulations thereof
CA2181165A1 (en) Anti-fungal methods and materials
AU3993795A (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
AU6579498A (en) Compounds and methods for the diagnosis and treatment of (ehrlichia) infection
WO1996038473A3 (en) Antimicrobial cationic peptides
WO1992015605A3 (en) Inhibitors of human neutrophil elastase and human cathepsin g
WO2000063246A3 (en) Compounds and methods for modulating beta-catenin mediated gene expression
CA2263181A1 (en) Anti-chlamydial methods and materials
HU9401260D0 (en) Fema gene of staphylococcus epidermis, fema protein, and vectors and microorganisms comprising the fema gene
MX9710252A (en) Use of one or more peptides in a cosmetic composition or for the preparation of a medicament.
AU2967595A (en) Anti-protozoan methods and materials
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
AU5537096A (en) Isolated frpb nucleic acid molecule and vaccine
CA2184175A1 (en) Isolated, tyrosinase derived peptides and uses thereof
EP0744176A3 (en) Methods for inhibiting bone loss
AU5981496A (en) Cell-cycle regulatory proteins from human pathogens, and use s related thereto
EP1174439A3 (en) Compositions and methods for treating infections using analogues of indolicidin
AU9334098A (en) Molecular diagnostic of glaucomas associated with chromosomes 1, and method of treatment thereof
EP1574579A3 (en) Outer surface proteins, their genes, and their use

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed